Core Viewpoint - The recent announcement by the National Medical Products Administration regarding the revision of the isotretinoin capsule instructions has raised significant attention due to the addition of new risk warnings related to its side effects [1][3]. Group 1: Side Effects and Risks - The revised instructions for isotretinoin now include numerous potential adverse reactions, such as endocrine, digestive, mental, and reproductive issues, with specific warnings about depression, agitation, and rare cases of suicidal thoughts or attempts [3][4]. - Reports of sexual dysfunction associated with isotretinoin have emerged, with some patients experiencing long-term symptoms even after discontinuation of the drug, potentially requiring specialized treatment [3][4]. - Common side effects include dryness of the skin, lips, and mucous membranes, which are generally mild and manageable, with most symptoms resolving after stopping the medication [4][5]. Group 2: Clinical Use and Recommendations - Isotretinoin is primarily used for treating acne, particularly severe nodular acne, due to its ability to address multiple factors contributing to acne development [3][4]. - Treatment typically starts with a standard dose, which may be reduced as the condition improves, helping to minimize adverse reactions; the entire treatment cycle usually lasts several months [3][4]. - The prescribing of isotretinoin requires careful evaluation by healthcare professionals, especially for patients with a history of mental health issues, and alternative treatments may be recommended for mild cases [5].
“战痘神药”异维A酸新增警示,或致抑郁与性功能障碍,专家提醒用药需谨慎评估
Xin Lang Cai Jing·2026-02-06 13:45